References
- Rahman I, Sadiq SA. Ophthalmic management of facial nerve palsy: a review. Surv Ophthalmol. 2007;52(2):121–144. doi:10.1016/j.survophthal.2006.12.009.
- Lee S, Lew H. Ophthalmologic clinical features of facial nerve palsy patients. Korean J Ophthalmol. 2019;33(1):1–7. doi:10.3341/kjo.2018.0010.
- MacIntosh PW, Fay AM. Update on the ophthalmic management of facial paralysis. Surv Ophthalmol. 2019;64(1):79–89. doi:10.1016/j.survophthal.2018.06.001.
- Lee V, Currie Z, Collin JR. Ophthalmic management of facial nerve palsy. Eye (Lond). 2004;18(12):1225–1234. doi:10.1038/sj.eye.6701383.
- Joseph SS, Joseph AW, Smith JI, Niziol LM, Musch DC, Nelson CC. Evaluation of patients with facial palsy and ophthalmic sequelae: a 23-year retrospective review. Ophthalmic Epidemiol. 2017;24(5):341–345. doi:10.1080/09286586.2017.1294186.
- Malhotra R, Ziahosseini K, Litwin A, Nduka C, El-Shammah N. CADS grading scale: towards better grading of ophthalmic involvement in facial nerve paralysis. Br J Ophthalmol. 2016;100(6):866–870. doi:10.1136/bjophthalmol-2015-307167.
- Meadows A, Hall N, Shah-Desai S, Low JL, Manners R. The house-brackmann system and assessment of corneal risk in facial nerve palsy. Eye (Lond). 2000;14(Pt 3A):353–357. doi:10.1038/eye.2000.87.
- Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope. 2014;124(7):E283–93. doi:10.1002/lary.24542.
- Eshraghi B, Ghadimi H, Nikdel M. Levator recession and minimal lateral tarsorrhaphy for the management of lagophthalmos and corneal exposure in facial palsy. Eur J Ophthalmol. 2021;31(1):57–60. doi:10.1177/1120672119881984.
- Chang L, Olver J. A useful augmented lateral tarsal strip tarsorrhaphy for paralytic ectropion. Ophthalmology. 2006;113(1):84–91. doi:10.1016/j.ophtha.2005.06.038.
- Sadiq SA, Downes RN. A clinical algorithm for the management of facial nerve palsy from an oculoplastic perspective. Eye (Lond). 1998;12(Pt 2):219–223. doi:10.1038/eye.1998.52.